MAURI, GIANLUCA
MAURI, GIANLUCA
Dipartimento di Oncologia ed Emato-Oncologia
A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin
2020 S. Arena, G. Corti, E. Durinikova, M. Montone, N.M. Reilly, M. Russo, A. Lorenzato, P. Arcella, L. Lazzari, G. Rospo, M. Pagani, C. Cancelliere, C. Negrino, C. Isella, A. Bartolini, A. Cassingena, A. Amatu, G. Mauri, A. Sartore-Bianchi, G. Mittica, E. Medico, S. Marsoni, M. Linnebacher, S. Abrignani, S. Siena, F. Di Nicolantonio, A. Bardelli
Application of histology-agnostic treatments in metastatic colorectal cancer
2022 A. Sartore-Bianchi, A.G. Agostara, G. Patelli, G. Mauri, E.G. Pizzutilo, S. Siena
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
2022 R. Moretto, A. Elliott, D. Rossini, R. Intini, V. Conca, F. Pietrantonio, A. Sartore-Bianchi, C. Antoniotti, C. Rasola, M. Scartozzi, M. Salati, N. Pella, M.A. Calegari, M. Carullo, F. Corti, G. Mauri, M. Fassan, G. Masi, P. Brodskiy, H. Lenz, A. Shields, S. Lonardi, M. Korn, C. Cremolini
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
2022 G. Mauri, G. Patelli, V. Gori, C. Lauricella, B. Mussolin, A. Amatu, K. Bencardino, F. Tosi, E. Bonazzina, E. Bonoldi, A. Bardelli, S. Siena, A. Sartore-Bianchi
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature
2021 G. Patelli, K. Bencardino, F. Tosi, M. Pugliano, F. Lanzani, A. Innocenti, A. Rinaldo, G. Mauri, G. Cerea, A. Sartore-Bianchi, M. Torre, E.C. Agostoni, S. Siena
Circulating tumor DNA to drive treatment in metastatic colorectal cancer
2023 G. Patelli, G. Mauri, F. Tosi, A. Amatu, K. Bencardino, E. Bonazzina, E.G. Pizzutilo, F. Villa, G. Calvanese, A.G. Agostara, S. Stabile, S. Ghezzi, G. Crisafulli, F. Di Nicolantonio, S. Marsoni, A. Bardelli, S. Siena, A. Sartore-Bianchi
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
2022 A. Sartore-Bianchi, F. Pietrantonio, S. Lonardi, B. Mussolin, F. Rua, G. Crisafulli, A. Bartolini, E. Fenocchio, A. Amatu, P. Manca, F. Bergamo, F. Tosi, G. Mauri, M. Ambrosini, F. Daniel, V. Torri, A. Vanzulli, D. Regge, G. Cappello, C. Marchiò, E. Berrino, A. Sapino, S. Marsoni, S. Siena, A. Bardelli
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression
2019 T. Cavalleri, P. Bianchi, G. Basso, G. Celesti, F. Grizzi, P. Bossi, L. Greco, C. Pitrone, E. Valtorta, G. Mauri, M. Truini, F.G. Dall'Olio, G. Brandi, A. Sartore-Bianchi, L. Ricciardiello, V. Torri, L. Rimassa, S. Siena, A. Mantovani, A. Malesci, L. Laghi
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
2022 G.M. Cavestro, A. Mannucci, F. Balaguer, H. Hampel, S.S. Kupfer, A. Repici, A. Sartore-Bianchi, T.T. Seppälä, V. Valentini, C.R. Boland, R.E. Brand, T.E. Buffart, C.A. Burke, R. Caccialanza, R. Cannizzaro, S. Cascinu, A. Cercek, E.J. Crosbie, S. Danese, E. Dekker, M. Daca-Alvarez, F. Deni, M. Dominguez-Valentin, C. Eng, A. Goel, J.G. Guillem, B.B.S.L. Houwen, C. Kahi, M.F. Kalady, F. Kastrinos, F. Kühn, L. Laghi, A. Latchford, D. Liska, P. Lynch, A. Malesci, G. Mauri, E. Meldolesi, P. Møller, K.J. Monahan, G. Möslein, C.C. Murphy, K. Nass, K. Ng, C. Oliani, E. Papaleo, S.G. Patel, M. Puzzono, A. Remo, L. Ricciardiello, C.I. Ripamonti, S. Siena, S.K. Singh, Z.K. Stadler, P.P. Stanich, S. Syngal, S. Turi, E.D. Urso, L. Valle, V.S. Vanni, E. Vilar, M. Vitellaro, Y.N. You, M.B. Yurgelun, R.A. Zuppardo, E.M. Stoffel
Early-onset colorectal cancer in young individuals
2019 G. Mauri, A. Sartore-Bianchi, A. Russo, S. Marsoni, A. Bardelli, S. Siena
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
2022 A. Amatu, G. Mauri, F.M. Tosi, K. Bencardino, E. Bonazzina, V. Gori, L. Ruggieri, S. Arena, A. Bardelli, S. Marsoni, S. Siena, A. SARTORE BIANCHI
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids
2021 G. Mauri, E. Durinikova, A. Amatu, F. Tosi, A. Cassingena, F. Rizzetto, K. Buzo, P. Arcella, M.C. Aquilano, E. Bonoldi, S. Marsoni, S. Siena, A. Bardelli, A. Sartore Bianchi, S. Arena
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
2023 V. Amodio, S. Lamba, R. Chilà, C.M. Cattaneo, B. Mussolin, G. Corti, G. Rospo, E. Berrino, C. Tripodo, F. Pisati, A. Bartolini, M.C. Aquilano, S. Marsoni, G. Mauri, C. Marchiò, S. Abrignani, F. Di Nicolantonio, G. Germano, A. Bardelli
Increased incidence of colon cancer among individuals younger than 50 years : a 17 years analysis from the cancer registry of the municipality of Milan, Italy
2019 A.G. Russo, A. Andreano, A. Sartore-Bianchi, G. Mauri, A. Decarli, S. Siena
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
2022 G. Mauri, P.P. Vitiello, A. Sogari, G. Crisafulli, A. Sartore-Bianchi, S. Marsoni, S. Siena, A. Bardelli
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
2021 G. Patelli, C. Vaghi, F. Tosi, G. Mauri, A. Amatu, D. Massihnia, S. Ghezzi, E. Bonazzina, K. Bencardino, G. Cerea, S. Siena, A. Sartore Bianchi
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer
2020 F. Tosi, A. Sartore Bianchi, S. Lonardi, A. Amatu, F. Leone, S. Ghezzi, C. Martino, K. Bencardino, E. Bonazzina, F. Bergamo, E. Fenocchio, E. Martinelli, T. Troiani, G. Siravegna, G. Mauri, V. Torri, G. Marrapese, E. Valtorta, A. Cassingena, G. Cappello, E. Bonoldi, A. Vanzulli, D. Regge, F. Ciardiello, V. Zagonel, A. Bardelli, L. Trusolino, S. Marsoni, S. Siena
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers
2021 V. Amodio, G. Mauri, N.M. Reilly, A. Sartore Bianchi, S. Siena, A. Bardelli, G. Germano
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report
2023 G. Mauri, V. Gori, G. Patelli, L. Roazzi, F. Rizzetto, L. De Carlis, A. Mariani, U. Cavallari, E. Prada, T. Cipani, M.C. Aquilano, E. Bonoldi, A. Vanzulli, S. Siena, A. Sartore-Bianchi
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge : Single Institution Series and Systematic Review Study
2016 K. Bencardino, G. Mauri, A. Amatu, F. Tosi, E. Bonazzina, L. Palmeri, M. Querques, F. Ravera, A. Menegotto, E. Boiani, A. SARTORE BIANCHI, S. Siena